How did Anuhelm, a new drug for Alzheimer’s disease, get approved? Elizabeth Tracey reports
Podcast: Download (Duration: 1:03 — 1.5MB)
Subscribe: RSS
Aducanumab or Aduhelm is a newly approved medicine for treating Alzheimer’s disease, with many experts asserting that it should never have gotten FDA approval. Caleb Alexander, an internal medicine expert at Johns Hopkins and a member of the FDA review …